Stay updated on Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page.

Latest updates to the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe page continues to display the version history for the PEARL clinical trial.SummaryDifference0.1%

- Check14 days agoChange DetectedThe site footer’s revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check21 days agoChange DetectedA site-wide NIH banner announces updates and FAQs about the transition from the term “Artificial Intelligence” to “Super Intelligence” across federal agencies.SummaryDifference0.4%

- Check28 days agoChange DetectedThe website footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check35 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check55 days agoChange DetectedThe history now shows a new revision entry for v3.7.0 and removes the previous v3.6.6 entry, indicating the page has been updated to reflect a newer revision.SummaryDifference0.1%

Stay in the know with updates to Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page.